Wuqiang Zhu Selected Research

Glucose (Dextrose)

1/2020

Targeting exosome-associated human antigen R attenuates fibrosis and inflammation in diabetic heart.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wuqiang Zhu Research Topics

Disease

12	Myocardial Infarction 10/2022 - 05/2009
9	Infarction (Infarctions) 01/2020 - 01/2012
5	Neoplasms (Cancer) 09/2023 - 01/2009
5	Cardiotoxicity 01/2019 - 01/2009
4	Hypertrophy 01/2018 - 09/2010
3	Heart Diseases (Heart Disease) 10/2022 - 01/2019
3	Fibrosis (Cirrhosis) 01/2020 - 01/2016
2	Heart Failure 10/2023 - 01/2017
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 01/2017
2	Ventricular Remodeling 01/2018 - 01/2016
1	Neoplasm Metastasis (Metastasis) 09/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Inflammation (Inflammations) 01/2020
1	Cicatrix (Scar) 12/2019
1	Disease Progression 01/2019
1	Hypersensitivity (Allergy) 11/2018
1	Carcinogenesis 11/2018
1	Cardiomegaly (Heart Hypertrophy) 12/2017
1	Reperfusion Injury 01/2017
1	Atrial Fibrillation 01/2012
1	Cardiomyopathies (Cardiomyopathy) 12/2011
1	Ischemia 05/2009

Drug/Important Bio-Agent (IBA)

4	Cyclin D2IBA 01/2021 - 12/2017
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2009
2	Fibroblast Growth Factor 1 (FGF-1)IBA 06/2022 - 01/2020
2	Chir 99021IBA 06/2022 - 01/2020
2	AcidsIBA 01/2022 - 01/2018
2	Y 27632IBA 10/2019 - 01/2019
2	AnthracyclinesIBA 01/2019 - 07/2014
2	CytokinesIBA 01/2018 - 01/2017
2	Calcium-Calmodulin-Dependent Protein KinasesIBA 12/2017 - 09/2010
1	gallium Ga 68 dotatateIBA 09/2023
1	LuciferasesIBA 10/2022
1	ChannelrhodopsinsIBA 10/2022
1	Capsules (Microcapsules)IBA 01/2022
1	Circular RNAIBA 01/2021
1	Angiotensin IIIBA 01/2020
1	LectinsIBA 01/2020
1	Cell Cycle ProteinsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Bromodeoxyuridine (BrdU)IBA 01/2020
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2020
1	Histones (Histone)IBA 01/2020
1	Troponin T (Troponin T1)IBA 01/2020
1	AntigensIBA 01/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 11/2018
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2018
1	TensinsIBA 11/2018
1	protein phosphatase 5IBA 11/2018
1	tissue-factor-pathway inhibitor 2 (PP5)IBA 11/2018
1	FibrinIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	CyclinsIBA 12/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2017
1	Natriuretic PeptidesIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	TroponinIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2016
1	diisopropylamine dichloroacetate (DIPA)IBA 01/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2012
1	gamma Catenin (Plakoglobin)IBA 12/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2011
1	CalciumIBA 09/2010
1	CXC ChemokinesIBA 05/2009
1	Chemokine CXCL12IBA 05/2009
1	CXCR ReceptorsIBA 05/2009
1	Free RadicalsIBA 01/2009
1	TOR Serine-Threonine KinasesIBA 01/2009

Therapy/Procedure

5	Transplantation 10/2022 - 01/2018
4	Therapeutics 10/2023 - 05/2009
3	Aftercare (After-Treatment) 01/2021 - 01/2018
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2016 - 05/2009
1	Cardiomyoplasty 01/2020
1	Cell Transplantation 10/2019
1	Drug Therapy (Chemotherapy) 01/2017
1	Ligation 01/2012